To update guidelines for preventing infections among hematopoietic cell transplant (HCT) recipients based on current data and practices.
Key Findings:
Infections remain a significant cause of morbidity and mortality among HCT recipients.
New antimicrobial agents and expanded conditioning regimens have changed infection prevention strategies.
The guidelines include new information on previously unaddressed organisms relevant to HCT patients.
The need for updated guidelines is underscored by the high rates of infection among HCT recipients.
Interpretation:
Despite advancements in HCT management, infection rates remain high, highlighting the necessity for updated and comprehensive guidelines for prevention.
Limitations:
Adherence to recommendations may vary based on local guidelines and resources.
Individual clinician practices may differ from the recommendations yet still be effective.
Local epidemiological conditions may impact adherence to the guidelines.
Conclusion:
The updated guidelines provide a structured approach to infection prevention in HCT recipients, addressing new challenges and incorporating recent evidence.
